Form D · Other Technology
OPACITY LABS, INC.
New York, NY · CIK 0002038604
Offering snapshot reported Oct 2, 2024 · SEC filing
- Reported sold
- $13.3M Offering amount: $13.8M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Mar 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 2, 2024 | Initial | $13,317,000 | No comparison | 48 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-525589
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Oct 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Bledsoe | Executive |
| Aaron Marz | Director |
| Hersh Patel | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1460 Broadway, 17 Th Floor
New York, NY, 10036
New York, NY, 10036